首页> 外文期刊>Radiation oncology >Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization
【24h】

Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization

机译:基于小波的常规栓塞术后CT图像对比肝细胞癌评价的基于小波的算法

获取原文
           

摘要

Background Hepatocellular carcinoma is a primary tumor of the liver and involves different treatment modalities according to the tumor stage. After local therapies, the tumor evaluation is based on the mRECIST criteria, which involves the measurement of the maximum diameter of the viable lesion. This paper describes a computed methodology to measure through the contrasted area of the lesions the maximum diameter of the tumor by a computational algorithm. Methods 63 computed tomography (CT) slices from 23 patients were assessed. Non-contrasted liver and HCC typical nodules were evaluated, and a virtual phantom was developed for this purpose. Optimization of the algorithm detection and quantification was made using the virtual phantom. After that, we compared the algorithm findings of maximum diameter of the target lesions against radiologist measures. Results Computed results of the maximum diameter are in good agreement with the results obtained by radiologist evaluation, indicating that the algorithm was able to detect properly the tumor limits. A comparison of the estimated maximum diameter by radiologist versus the algorithm revealed differences on the order of 0.25 cm for large-sized tumors (diameter?>?5 cm), whereas agreement lesser than 1.0 cm was found for small-sized tumors. Conclusions Differences between algorithm and radiologist measures were accurate for small-sized tumors with a trend to a small decrease for tumors greater than 5 cm. Therefore, traditional methods for measuring lesion diameter should be complemented non-subjective measurement methods, which would allow a more correct evaluation of the contrast-enhanced areas of HCC according to the mRECIST criteria.
机译:背景技术肝细胞癌是肝脏的主要肿瘤,并且根据肿瘤阶段涉及不同的治疗方式。在局部疗法后,肿瘤评估基于MRECART标准,涉及测量可行性病变的最大直径。本文介绍了计算方法,以通过计算算法通过肿瘤的最大直径测量来测量肿瘤的最大直径。方法评估来自23例患者的63个计算断层扫描(CT)切片。评估非对比性肝脏和HCC典型结节,为此目的开发了虚拟幻影。使用虚拟幻像进行算法检测和量化的优化。之后,我们将靶位病变的最大直径的算法结果进行了比较免放射科措施。结果最大直径的计算结果与放射科学评估所获得的结果吻合良好,表明该算法能够正确地检测肿瘤限制。放射科学估计的最大直径与算法的比较显示,对于大型肿瘤的0.25厘米(直径?> 5cm),差异显示差异,而小于小肿瘤,则发现比1.0厘米更小的协议。结论算法与放射科学措施之间的差异对于小尺寸肿瘤的趋势是准确的,肿瘤的趋势较小,肿瘤大于5厘米。因此,用于测量病变直径的传统方法应补充非主观测量方法,这将根据MRECAST标准更好地评估HCC的对比度增强区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号